Located in Jiangsu Medpark in Suzhou New District, Sandstone Medical focuses on the development, production, and marketing of drug infusion consumables. Since its founding in 2018, it has obtained ISO 13485, EU CE, U.S. FDA registration, MDSAP, ANVISA in Brazil, and Japan’s FMR under the PMD Act.

To ensure consistent product quality and performance, the company introduced automated molding, assembly, and packaging equipment from Germany, Japan, and South Korea. It also developed in-house inspection systems for key production stages, enabling image-based detection and real-time quality adjudication.

Sandstone Medical provides a range of insulin pen needles specifically designed for diabetic users, supporting safe and comfortable insulin delivery in everyday settings. With a focus on reliability and user safety, the company works closely with partners to improve care efficiency and protect the well-being of those managing diabetes.